G Medical Innovations Holdings Ltd. Reports Financial Results for the Six Months Ended June 30, 2021, with Revenue up 45.5% Demand for patient monitoring services recovering with revenue increasing 45.5% in first half of 2021Accelerating growth strategy with expansion of Prizma and Cardiac sales team UnityPoint Prizma...

G Medical Innovations Holdings Ltd. Sets Date to Announce Half Year Results for the Six Months Ended June 30, 2021  TEL AVIV and NEW YORK, Sept. 01, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- G Medical Innovations Holdings Ltd. (NASDAQ:GMVD) (the "Company"), a telehealth, medical device, and remote patient...

G Medical Innovations Holdings Ltd. Announces Closing of $15.0 Million Initial Public Offering TEL AVIV and NEW YORK , June 29, 2021 (GLOBE NEWSWIRE) -- G Medical Innovations Holdings Ltd. (NASDAQ:GMVD) (the "Company"), a telehealth, medical device, and remote patient monitoring company...

G Medical Innovations Holdings Ltd. Announces Pricing of $15.0 Million Initial Public Offering and Nasdaq Listing TEL AVIV and NEW YORK, June 24, 2021 (GLOBE NEWSWIRE) -- G Medical Innovations Holdings Ltd. (NASDAQ:GMVD) (the "Company"), a telehealth, medical device, and remote patient monitoring company...

G MEDICAL INNOVATIONS HOLDINGS LTD. ANNOUNCES FILING OF SEC REGISTRATION STATEMENT FOR PROPOSED NASDAQ INITIAL PUBLIC OFFERING Tel Aviv and New York , Oct. 22, 2020 (GLOBE NEWSWIRE) -- G Medical Innovations Holdings Ltd. (“GMed”), a telehealth, medical device, and remote patient monitoring company providing clinical-grade...